Medtronic Financial Statements From 2010 to 2024
| MDTC34 Stock | BRL 245.59 0.40 0.16% |
Check Medtronic Plc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medtronic Plc's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medtronic financial statements analysis is a perfect complement when working with Medtronic Plc Valuation or Volatility modules.
Medtronic |
Medtronic plc Company Return On Asset Analysis
Medtronic Plc's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medtronic Plc Return On Asset | 0.0422 |
Most of Medtronic Plc's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medtronic plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medtronic plc has a Return On Asset of 0.0422. This is 100.48% lower than that of the Healthcare sector and 100.23% lower than that of the Medical Devices industry. The return on asset for all Brazil stocks is 130.14% lower than that of the firm.
Medtronic plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medtronic Plc's current stock value. Our valuation model uses many indicators to compare Medtronic Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medtronic Plc competition to find correlations between indicators driving Medtronic Plc's intrinsic value. More Info.Medtronic plc is regarded fourth in return on equity category among its peers. It is regarded fifth in return on asset category among its peers reporting about 0.51 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medtronic plc is roughly 1.97 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medtronic Plc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medtronic Plc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Medtronic Plc Financial Statements
Medtronic Plc stakeholders use historical fundamental indicators, such as Medtronic Plc's revenue or net income, to determine how well the company is positioned to perform in the future. Although Medtronic Plc investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medtronic Plc's assets and liabilities are reflected in the revenues and expenses on Medtronic Plc's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medtronic plc. Please read more on our technical analysis and fundamental analysis pages.
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. MEDTRONIC DRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 90000 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Medtronic Stock
When determining whether Medtronic plc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:Check out the analysis of Medtronic Plc Correlation against competitors. For information on how to trade Medtronic Stock refer to our How to Trade Medtronic Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.